Breathing new life into mature medicines

Our purpose, our mission and our principles

Tree graphic with pink and plue leaves

Our purpose

Our focus is mature branded medicines globally. We want to be the preferred acquirer for large cap or speciality pharma businesses choosing to divest their "mature", "established" or "tail" off-patent branded medicines. We commit to continue the high-quality manufacturing and management of the medicines. At the same time, we aspire to breathe new life into the medicines, investing in them to make them stable and sustainable over the long-term.

Watering can watering some flowers

Our mission

Our mission is simple. We want to deliver medicines that our patients, healthcare systems and regulators value. We want to grow our business such that is balanced from both a portfolio and market perspective. We want to maintain a simple, lean operating model, working with partners wherever we can.

Handshake illustration

Our principles

First and foremost, our responsibility is to our patients. We promise to adhere to the highest standards of medical practice and to deliver high-quality medicines; to be a responsible business that acts fairly and honestly at all times; and to manage our supply chain responsibly. We give equal opportunities to our employees, welcome different viewpoints and perspectives, and create a workplace free from harassment and bullying.

The preferred acquirer for large cap or speciality pharma businesses choosing to divest

We want to be the preferred acquirer for large cap or speciality pharma businesses choosing to divest choosing to divest their "mature", 'established" or "tail" off-patent branded medicines. We recognise that they may have different reasons for choosing to divest, and will have different requirements at different stages of the sale process. We understand these requirements intrinsically and believe we are uniquely positioned to meet them.

1

Pre-completion

We can arrive at and make an offer quickly. We will consider acquisitions of individual medicines or territories, or bundles of medicines or territories globally. We have a simple capital structure enabling us to complete acquisitions rapidly.

2

During transition

We are an efficient and experienced transaction counterparty. We have a tried-and-tested transition methodology.

3

Post-transition

We are a trusted and diligent caretaker of the brand. We have built a platform that can absorb and manage on an ongoing basis new acquisitions seamlessly.

Looking to license or divest a medicine?

Or are you a CMO or distributor who wishes to partner with us?

Get in touch